Immune involvement in neuropsychiatric disorders: Insights from single‐cell transcriptomic studies
Psychiatry and Clinical Neurosciences · 2026-04 · 80 (4) · 241-249
DOI: 10.1111/pcn.70018 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Psychiatry and Clinical Neurosciences, online erschienen am 27.12.2025. Verfasst von Tsutomu Takeda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Transformative Psychiatry and Synergistic Research, International Center for Brain Sciences, Fujita Health University, Aichi, Japan. Hauptthemen laut MEDLINE: Single-Cell Analysis, Mental Disorders, Transcriptome, Gene Expression Profiling. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Moonshot Research and Development Program, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Neuropsychiatric disorders pose profound challenges to both research and treatment, largely due to their clinical heterogeneity and the limited understanding of their underlying biological mechanisms. While bulk RNA sequencing (bulk RNA‐seq) has been widely used to study gene expression, it cannot resolve cell‐type‐specific signals or detect rare cellular subpopulations. In contrast, single‐cell RNA sequencing (scRNA‐seq) and single‐nucleus RNA sequencing (snRNA‐seq) have emerged as transformative technologies, enabling transcriptomic profiling at single‐cell resolution. These approaches have revealed immunological alterations across a wide range of disorders. This review introduces recent findings from sc/snRNA‐seq studies of immune‐related mechanisms in psychiatric disorders—including schizophrenia, bipolar disorder, major depressive disorder, autism spectrum disorder, and attention‐deficit/hyperactivity disorder—as well as in neurological conditions such as Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies, multiple sclerosis, and anti‐NMDA receptor encephalitis. While sc/snRNA‐seq overcome averaging effects of bulk RNA‐seq by resolving cell types, these methods still face challenges. We outline a roadmap that integrates bulk RNA‐seq and sc/snRNA‐seq to mitigate the remaining gaps.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Transformative Psychiatry and Synergistic Research, International Center for Brain Sciences, Fujita Health University, Aichi, Japan.
- Department of Psychiatry, Fujita Health University School of Medicine, Aichi, Japan.
- Department of Psychiatry, Nara Medical University School of Medicine, Nara, Japan.
- Department of Neuropsychiatry, Kumamoto University, Kumamoto, Japan.
ORCID-Profile: Manabu Makinodan
Förderung
- Moonshot Research and Development Program
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Takeda, T., Toritsuka, M., Tamakoshi, H., Iwata, N., & Makinodan, M. (2026). Immune involvement in neuropsychiatric disorders: Insights from single‐cell transcriptomic studies. Psychiatry and Clinical Neurosciences, 80(4), 241-249. https://doi.org/10.1111/pcn.70018
Vancouver
Takeda T, Toritsuka M, Tamakoshi H, Iwata N, Makinodan M. Immune involvement in neuropsychiatric disorders: Insights from single‐cell transcriptomic studies. Psychiatry and Clinical Neurosciences. 2026;80(4):241-249. doi:10.1111/pcn.70018
BibTeX
@article{Takeda2026,
author = {Takeda, Tsutomu and Toritsuka, Michihiro and Tamakoshi, Hiroto and Iwata, Nakao and Makinodan, Manabu},
title = {Immune involvement in neuropsychiatric disorders: Insights from single‐cell transcriptomic studies},
journal = {Psychiatry and Clinical Neurosciences},
year = {2026},
volume = {80},
number = {4},
pages = {241--249},
doi = {10.1111/pcn.70018}
}
EUVIMED